NCT04693611
- Conditions
- Brain Diseases, Central Nervous System Diseases, Cognition Disorders, +8 more
- Locations
-
- Cediara - Social Solidarity Association of Ribeira de Fráguas Ribeira de Fráguas, Albergaria-a-Velha, Portugal
Clinical trial condition
Cognitive Dysfunction
Explore clinical trials studying Cognitive Dysfunction. Study availability and eligibility vary by location and protocol.
2,844 public trials
620 recruiting studies
Cognitive Dysfunction trial results
NCT04480112
- Conditions
- Alzheimer Disease, Behavior, Brain Diseases, +18 more
- Locations
-
- Boston University Alzheimer Disease Center Boston, Massachusetts, United States
Completed
Cognitive Training and Social Interaction Effects on Cognitive Performance of Older Adults
NCT05016336
- Conditions
- Cognition Disorders, Cognitive Decline, Cognitive Dysfunction, +2 more
- Locations
-
- Bar Ilan University Ramat Gan, Israel
NCT04248400
- Conditions
- Cognition Disorders, Cognitive Dysfunction, Mental Disorders, +2 more
- Locations
-
- The University of Hong Kong Hong Kong
NCT03827954
- Conditions
- Cardiovascular Diseases, Cognition Disorders, Cognitive Dysfunction, +5 more
- Locations
-
- University of South Florida Tampa, Florida, United States
Completed
Olfactory Deficits in Neurologic Disease
NCT05019014
- Conditions
- Alzheimer Disease, Amyotrophic Lateral Sclerosis, Basal Ganglia Diseases, +30 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT01823666
- Conditions
- Alzheimer Disease, Arterial Occlusive Diseases, Arteriosclerosis, +18 more
- Locations
-
- Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine Beijing, Beijing Municipality, China
NCT03475316
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +11 more
- Locations
-
- Albert Einstein College of Medicine The Bronx, New York, United States
NCT03081546
- Conditions
- Cognition Disorders, Cognitive Dysfunction, Healthy Controls, +3 more
- Locations
-
- University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
Completed
Evaluation of Lithium as a Glycogen-Synthase-Kinase-3 (GSK-3) Inhibitor in Mild Cognitive Impairment
NCT02601859
- Conditions
- Cognition Disorders, Cognitive Dysfunction, Mental Disorders, +2 more
- Locations
-
Not specified